EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Pediatric Vulvar Lichen Sclerosus: Is a One-Size-Fits-All Prolonged Induction Therapeutic Regimen Effective? A Referral Center Experience

Veronica Boero, Carlotta Caia, Maria Mastrangelo, Francesca Accomasso, Elisa Restelli, Riccardo Cavalli, Francesca Montefusco, Giada Libutti, Alfredo Berrettini, Elisa Pesce, Chiara Pillinini, Giulia E Cetera und 1 weitere

Journal of Pediatric and Adolescent Gynecology · 2025

DOI: 10.1016/j.jpag.2025.12.005 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Pediatric and Adolescent Gynecology, 2025. Verfasst von Veronica Boero und 12 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: veronica.boero@policlinico.mi.it. Hauptthemen laut MEDLINE: Vulvar Lichen Sclerosus, Clobetasol, Emollients, Glucocorticoids. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STUDY OBJECTIVE: To evaluate the efficacy and safety of a prolonged 6-month induction regimen using ultrapotent topical corticosteroids and daily emollient in the treatment of pediatric vulvar lichen sclerosus (pVLS). METHODS: This retrospective observational study included 94 girls with clinical diagnosis of pVLS between 2021 and 2025. All patients underwent a standardized treatment protocol with clobetasol propionate 0.05% ointment applied daily for 30 days, every other day for 30 days, and twice weekly for 120 days, alongside daily application of a vitamin E-based emollient. Clinical evaluations and symptom assessments were conducted at baseline (T0), 3 months (T1), and 6 months (T2). RESULTS: Symptom remission was achieved in 83% of patients, with marked reductions in itching from 80% (T0) to 13% (T2), *P* < .001, and burning from 36% (T0) to 8% (T2), *P* < .001. Dysuria, dyschezia, and nocturnal awakenings resolved completely by the T1 follow-up. Significant improvements in clinical signs were observed in vulvar area. Improvements in perianal signs were more modest but statistically significant for fissures/erosions (P < .001) and hyperkeratosis/lichenification (P = .018). No significant changes were observed in anatomical alterations. Mild, self-limiting side effects were reported in 8% of patients at T1 and in only 1% at T2. No serious adverse events occurred. CONCLUSION: A prolonged induction regimen with ultrapotent topical corticosteroids demonstrates high efficacy with a substantial symptom and sign resolution and favorable safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vulvar Lichen SclerosusClobetasolEmollientsGlucocorticoidsHumansFemaleRetrospective StudiesChildAdolescentTreatment OutcomeVitamin ERemission InductionChild, Preschool

Stichwörter der Autor:innen

Pediatric dermatologyPediatric gynecologyTopical corticosteroidsVulvar lichen sclerosus

Substanzen

ClobetasolEmollientsGlucocorticoidsVitamin E

Autor:innen und Institutionen

  • Gynecology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: veronica.boero@policlinico.mi.it.
  • Gynecology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Clinical Sciences and Community Health, Università degli Studi, Milano, Italy; Fondazione IRCCS Ca' Granda Ospedale…
  • Gynecology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Surgical Sciences, Gynecology and Obstetrics Unit, Mauriziano Umberto I Hospital, University of Turin, Turin, Italy.
  • Pediatric Dermatology Unit, Foundation IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  • Pediatric Urology Unit, Foundation IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Zitieren

APA

Boero, V., Caia, C., Mastrangelo, M., Accomasso, F., Restelli, E., Cavalli, R., Montefusco, F., Libutti, G., Berrettini, A., Pesce, E., Pillinini, C., Cetera, G. E., & Somigliana, E. (2025). Pediatric Vulvar Lichen Sclerosus: Is a One-Size-Fits-All Prolonged Induction Therapeutic Regimen Effective? A Referral Center Experience. Journal of Pediatric and Adolescent Gynecology. https://doi.org/10.1016/j.jpag.2025.12.005

Vancouver

Boero V, Caia C, Mastrangelo M, Accomasso F, Restelli E, Cavalli R, et al. Pediatric Vulvar Lichen Sclerosus: Is a One-Size-Fits-All Prolonged Induction Therapeutic Regimen Effective? A Referral Center Experience. Journal of Pediatric and Adolescent Gynecology. 2025. doi:10.1016/j.jpag.2025.12.005

BibTeX
@article{Boero2025,
  author = {Boero, Veronica and Caia, Carlotta and Mastrangelo, Maria and Accomasso, Francesca and Restelli, Elisa and Cavalli, Riccardo and Montefusco, Francesca and Libutti, Giada and Berrettini, Alfredo and Pesce, Elisa and Pillinini, Chiara and Cetera, Giulia E and Somigliana, Edgardo},
  title = {Pediatric Vulvar Lichen Sclerosus: Is a One-Size-Fits-All Prolonged Induction Therapeutic Regimen Effective? A Referral Center Experience},
  journal = {Journal of Pediatric and Adolescent Gynecology},
  year = {2025},
  doi = {10.1016/j.jpag.2025.12.005}
}
Kostenlos starten →